Ligand id: 7378

Name: IMCgp100

No information available.
Summary of Clinical Use
This potential therapeutic is in clinical trial for the treatment of advanced stage malignant melanoma. Although the assessment group was small, the preliminary results of Phase I/II trials have been encouraging, with the therapy showing good tolerability and tumour volume reduction in some patients. Click here to link to's complete list of clinical trials assessing IMCgp100 as a cancer treatment.